Cargando…

A novel diagnostic model for insulinoma

The aim is to describe a simple and feasible model for the diagnosis of insulinoma. This retrospective study enrolled 37 patients with insulinoma and 44 patients with hypoglycemia not due to insulinoma at the First Affiliated Hospital of Guangxi Medical University. General demographic and clinical c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feng, Yang, Zhe, Chen, XiuBing, Peng, Yiling, Jiang, HaiXing, Qin, ShanYu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346017/
https://www.ncbi.nlm.nih.gov/pubmed/35916979
http://dx.doi.org/10.1007/s12672-022-00534-w
_version_ 1784761554883837952
author Wang, Feng
Yang, Zhe
Chen, XiuBing
Peng, Yiling
Jiang, HaiXing
Qin, ShanYu
author_facet Wang, Feng
Yang, Zhe
Chen, XiuBing
Peng, Yiling
Jiang, HaiXing
Qin, ShanYu
author_sort Wang, Feng
collection PubMed
description The aim is to describe a simple and feasible model for the diagnosis of insulinoma. This retrospective study enrolled 37 patients with insulinoma and 44 patients with hypoglycemia not due to insulinoma at the First Affiliated Hospital of Guangxi Medical University. General demographic and clinical characteristics; hemoglobin A1c (HbA1c), insulin and C-peptide concentrations; and the results of 2-h oral glucose tolerance tests (OGTT) were recorded, and a logistic regression model predictive of insulinoma was determined. Body mass index (BMI), HbA1c concentration, 0-h C-peptide concentration, and 0-h and 1-h plasma glucose concentrations (P < 0.05 each) were independently associated with insulinoma. A regression prediction model was established through multivariate logistics regression analysis: Logit p = 7.399+(0.310 × BMI) − (1.851 × HbA1c) − (1.467 × 0-h plasma glucose) + (1.963 × 0-h C-peptide) − (0.612 × 1-h plasma glucose). Using this index to draw a receiver operating characteristic (ROC) curve, the area under the curve (AUC) was found to be 0.957. The optimal cut-off value was − 0.17, which had a sensitivity of 89.2% and a specificity of 86.4%. Logit P ≥ − 0.17 can be used as a diagnostic marker for predicting insulinoma in patients with hypoglycemia.
format Online
Article
Text
id pubmed-9346017
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-93460172022-08-04 A novel diagnostic model for insulinoma Wang, Feng Yang, Zhe Chen, XiuBing Peng, Yiling Jiang, HaiXing Qin, ShanYu Discov Oncol Research The aim is to describe a simple and feasible model for the diagnosis of insulinoma. This retrospective study enrolled 37 patients with insulinoma and 44 patients with hypoglycemia not due to insulinoma at the First Affiliated Hospital of Guangxi Medical University. General demographic and clinical characteristics; hemoglobin A1c (HbA1c), insulin and C-peptide concentrations; and the results of 2-h oral glucose tolerance tests (OGTT) were recorded, and a logistic regression model predictive of insulinoma was determined. Body mass index (BMI), HbA1c concentration, 0-h C-peptide concentration, and 0-h and 1-h plasma glucose concentrations (P < 0.05 each) were independently associated with insulinoma. A regression prediction model was established through multivariate logistics regression analysis: Logit p = 7.399+(0.310 × BMI) − (1.851 × HbA1c) − (1.467 × 0-h plasma glucose) + (1.963 × 0-h C-peptide) − (0.612 × 1-h plasma glucose). Using this index to draw a receiver operating characteristic (ROC) curve, the area under the curve (AUC) was found to be 0.957. The optimal cut-off value was − 0.17, which had a sensitivity of 89.2% and a specificity of 86.4%. Logit P ≥ − 0.17 can be used as a diagnostic marker for predicting insulinoma in patients with hypoglycemia. Springer US 2022-08-02 /pmc/articles/PMC9346017/ /pubmed/35916979 http://dx.doi.org/10.1007/s12672-022-00534-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Wang, Feng
Yang, Zhe
Chen, XiuBing
Peng, Yiling
Jiang, HaiXing
Qin, ShanYu
A novel diagnostic model for insulinoma
title A novel diagnostic model for insulinoma
title_full A novel diagnostic model for insulinoma
title_fullStr A novel diagnostic model for insulinoma
title_full_unstemmed A novel diagnostic model for insulinoma
title_short A novel diagnostic model for insulinoma
title_sort novel diagnostic model for insulinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346017/
https://www.ncbi.nlm.nih.gov/pubmed/35916979
http://dx.doi.org/10.1007/s12672-022-00534-w
work_keys_str_mv AT wangfeng anoveldiagnosticmodelforinsulinoma
AT yangzhe anoveldiagnosticmodelforinsulinoma
AT chenxiubing anoveldiagnosticmodelforinsulinoma
AT pengyiling anoveldiagnosticmodelforinsulinoma
AT jianghaixing anoveldiagnosticmodelforinsulinoma
AT qinshanyu anoveldiagnosticmodelforinsulinoma
AT wangfeng noveldiagnosticmodelforinsulinoma
AT yangzhe noveldiagnosticmodelforinsulinoma
AT chenxiubing noveldiagnosticmodelforinsulinoma
AT pengyiling noveldiagnosticmodelforinsulinoma
AT jianghaixing noveldiagnosticmodelforinsulinoma
AT qinshanyu noveldiagnosticmodelforinsulinoma